“India’s problem is the world’s problem”, says Yasmeen Serhan in The Atlantic. Just weeks ago, the country thought it had put the Covid-19 pandemic behind it. Then it reported more than a million new cases and over 8,000 deaths over a three-day period, setting grim new global records in the process. As the virus sweeps through developing countries “the world is on track to record more Covid-19 deaths this year than it did in 2020”.
Difficult months ahead
India’s tragedy has exposed a fragile medical system, says Michael Safi in The Guardian. It spends just 1% of GDP on its state healthcare service, one of the lowest figures in the world. The country was the world’s biggest vaccine producer heading into the pandemic but vaccinating 1.39 billion people is no easy task: less than 10% of the population has received a first shot.
Prime Minister Narendra Modi had boasted that the country had become the “world’s pharmacy”. India has exported 66 million vaccine doses since January even as its own health system has buckled, notes Hasit Shah for Quartz. Many low and middle-income countries were counting on deliveries of Indian-produced jabs that will now be delayed or diverted.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
India’s economy had been enjoying “a remarkably strong recovery” before the latest wave, says Capital Economics in a note. GDP is thought to have returned to pre-pandemic levels as early as the final quarter of last year and early data showed continued strong progress in the first three months of 2021. The International Monetary Fund had predicted a blistering 12.5% GDP growth rate for 2021. A strong Indian outlook helped drive optimistic forecasts for emerging markets, says Udith Sikand for Gavekal Research. Yet with the news from India growing ever worse, growth in developing countries (excluding China) is likely to undershoot that of developed markets this year.
More pressure on emerging markets
The benchmark BSE Sensex index has been broadly flat since the start of the year but has fallen by 7% since the middle of February. The rupee has slipped by 2.2% against the US dollar since the start of April, says Sikand. That makes it Asia’s worst-performing currency this quarter. International investors have been pulling back, reports Steve Goldstein for Barron’s. As of 23 April, foreign money managers had sold $814m of Indian stocks in April. The country is likely to see “net selling” of its assets for the first time in seven months.
The big worry in emerging markets had been that we were heading for “a repeat of 2013”, when spiking US bond yields sparked turmoil across world markets, says The Economist. In the event, the rise in US bond yields has cooled of late, giving countries such as Brazil, India and South Africa some financial respite. Instead, the new fear is that 2021 will turn out to be a depressing “repeat of last year”. Several Latin American countries are already experiencing second waves as bad as India’s. Many low-income countries are struggling to vaccinate their people. The grim scenes in India could yet be repeated elsewhere.
-
Rachel Reeves faces £23 billion capital gains tax “black hole” – will she be forced to look elsewhere?The fiscal watchdog has downgraded its forecast for capital gains tax revenues, leaving chancellor Rachel Reeves with £23 billion less than previously expected
-
Protests erupt in Turkey after the arrest of Erdogan's rivalTurkey's president has jailed his main political opponent, Ekrem Imamoglu
-
Large cap stocks start to struggle – is it time for investors to reassess their focus?Buying quality large caps worked very well last decade. A more volatile world will be a bigger challenge for these star stocks, says Cris Sholto Heaton
-
How to generate income with fixed-interest investmentsPublic debt is overvalued, but other fixed-interest investments now look like a bargain, says Max King
-
Three top-notch Taiwanese companies cashing in on the advent of AIOpinion Eric Chan, investment director and co-manager of the Aberdeen Asian Income Fund, highlights three potential Taiwanese winners in the technology industry
-
Weight-loss drugs could revolutionise the economy – the investments to buy nowThe new generation of weight-loss drugs are a boon for the overweight, but they also promise to change our relationship with food and revolutionise the economy
-
Find tomorrow’s Asian giants while they are still smaller companiesOpinion Nitin Bajaj, portfolio manager of the Fidelity Asian Values trust, picks three Asian companies to invest in.
-
AI will maintain Moody’s market lead, says Stephen ConnollyOpinion Veteran data provider Moody's has adapted well to the modern world, and is one of Warren Buffett’s longest-held investments
-
Is BlackRock World Mining gearing for a recovery?Opinion After a frustrating year, BlackRock World Mining is positioned for growth and to capitalise on the sector's recovery
-
Should you limit exposure to US tech stocks?An end to the AI boom would shake both US funds and global trackers. Here’s one way to trim exposure to US tech stocks
